Theravance Biopharma
TBPH
TBPH
107 hedge funds and large institutions have $1.09B invested in Theravance Biopharma in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 41 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.12% less ownership
Funds ownership: 83.21% → 82.09% (-1.1%)
27% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 41
Holders
107
Holding in Top 10
1
Calls
$2.72M
Puts
$2.11M
Top Buyers
| 1 | +$40.8M | |
| 2 | +$3.84M | |
| 3 | +$2.92M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$2.27M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.11M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$8.8M | |
| 3 | -$8.34M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.74M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$3.01M |